Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNA-638 inhibits the progression of breast cancer through targeting HOXA9 and suppressing Wnt/β-cadherin pathway
Qian Xu, Qianqian Zhang, Mengli Dong, et al.
World Journal of Surgical Oncology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 18

Showing 18 citing articles:

Beneficial and detrimental aspects of miRNAs as chief players in breast cancer: A comprehensive review
Ahmed Ismail, Hesham A. El-Mahdy, Ahmed I. Abulsoud, et al.
International Journal of Biological Macromolecules (2022) Vol. 224, pp. 1541-1565
Closed Access | Times Cited: 66
Crosstalk of miRNAs with signaling networks in bladder cancer progression: Therapeutic, diagnostic and prognostic functions
Mehrdad Hashemi, Hamid Zaferani Arani, Sima Orouei, et al.
Pharmacological Research (2022) Vol. 185, pp. 106475-106475
Closed Access | Times Cited: 21
HOXA9 Overexpression Contributes to Stem Cell Overpopulation That Drives Development and Growth of Colorectal Cancer
Brian T. Osmond, Caroline O. Facey, Chi Zhang, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 12, pp. 6799-6799
Open Access | Times Cited: 16
HOXA9 transcription factor is a double-edged sword: from development to cancer progression
U Sangeetha Shenoy, Divya Adiga, Faisal Suliman Alhedyan, et al.
Cancer and Metastasis Reviews (2023) Vol. 43, Iss. 2, pp. 709-728
Open Access | Times Cited: 9
Role of HOXA9 in solid tumors: mechanistic insights and therapeutic potential
Ling Tang, Peng Lin, Chao Tan, et al.
Cancer Cell International (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Bone marrow mesenchymal/fibroblastic stromal cells induce a distinctive EMT-like phenotype in AML cells
Natalia Nojszewska, O. Idilli, D. Sarkar, et al.
European Journal of Cell Biology (2023) Vol. 102, Iss. 3, pp. 151334-151334
Open Access | Times Cited: 6
siRNA and targeted delivery systems in breast cancer therapy
Sepideh Mirzaei, Mahshid Deldar Abad Paskeh, Maliheh Entezari, et al.
Clinical & Translational Oncology (2022) Vol. 25, Iss. 5, pp. 1167-1188
Closed Access | Times Cited: 10
LINC01140 regulates osteosarcoma proliferation and invasion by targeting the miR-139-5p/HOXA9 axis
Shufang Zhang, Rongchun Chen
Biochemistry and Biophysics Reports (2022) Vol. 31, pp. 101301-101301
Open Access | Times Cited: 9
The potent potential of MFAP2 in prognosis and immunotherapy of triple-negative breast cancer
Jing‐Long Huang, Yuting Xu, Shengnan Qi, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
The importance of the circRNA/Wnt axis in gliomas: biological functions and clinical opportunities
Neda Hedayati, Alireza Mafi, Aryan Farahani, et al.
Pathology - Research and Practice (2024) Vol. 261, pp. 155510-155510
Closed Access | Times Cited: 1
Deciphering the Enigmatic Influence: Non-Coding RNAs Orchestrating Wnt/β-Catenin Signaling Pathway in Tumor Progression
Xinbing Yang, Yajing Du, Lulu Luo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 13909-13909
Open Access | Times Cited: 4
Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer
Menglin He, Cheng Hu, Jian Deng, et al.
World Journal of Surgical Oncology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 9
NR2F1-AS1 Acts as an Oncogene in Breast Cancer by Competitively Binding with miR-641
Yan Zhong, Weiwei Zeng
Journal of Healthcare Engineering (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 5
miR-638: A Promising Cancer Biomarker with Therapeutic Potential
Elham Hasheminasabgorji, Mohammad Amir Mishan, Mohammad Amin Khazeei Tabari, et al.
Current Molecular Medicine (2022) Vol. 23, Iss. 5, pp. 377-389
Closed Access | Times Cited: 5
MiR‐600 mediates EZH2/RUNX3 signal axis to modulate breast cancer cell viability and sorafenib sensitivity
Qian Zhao, Dan Li, Jinchun Feng, et al.
Journal of Biochemical and Molecular Toxicology (2023) Vol. 38, Iss. 1
Closed Access | Times Cited: 2
Non-coding RNA-related antitumor mechanisms of marine-derived agents
Zhixia Zhou, Qianqian Cao, Yujing Diao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Exploring the expression and clinical significance of the miR-140-3p-HOXA9 axis in colorectal cancer
Wei Cui, Bai Xueliang, Zhongyuan Bai, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 2
Open Access
HOXA9 versus HOXB9; particular focus on their controversial role in tumor pathogenesis
Ahmed Hjazi, Saade Abdalkareem Jasim, Aiman Mohammed Baqir Al‐Dhalimy, et al.
Journal of Applied Genetics (2024) Vol. 65, Iss. 3, pp. 473-492
Closed Access
Page 1

Scroll to top